LifeMD, Inc.
LFMD
$3.40
$0.133.98%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 204.49M | 206.22M | 206.95M | 165.57M | 158.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 204.49M | 206.22M | 206.95M | 165.57M | 158.67M |
| Cost of Revenue | 24.64M | 26.20M | 28.41M | 29.19M | 26.79M |
| Gross Profit | 179.84M | 180.03M | 178.54M | 136.38M | 131.88M |
| SG&A Expenses | 179.61M | 175.15M | 166.66M | 132.45M | 131.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 11.10M | 10.93M | 10.13M | 9.12M | 8.32M |
| Total Operating Expenses | 223.61M | 220.57M | 213.54M | 177.03M | 172.16M |
| Operating Income | -19.13M | -14.34M | -6.60M | -11.47M | -13.49M |
| Income Before Tax | -20.42M | -16.34M | -9.11M | -14.62M | -15.78M |
| Income Tax Expenses | 183.00K | 183.00K | 183.00K | 534.60K | 598.00K |
| Earnings from Continuing Operations | -20.60 | -16.52 | -9.30 | -15.15 | -16.38 |
| Earnings from Discontinued Operations | 21.03M | 22.92M | 24.92M | 3.89M | 3.89M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -228.80K | -733.90K | -1.27M | -1.60M | -1.22M |
| Net Income | 201.10K | 5.67M | 14.35M | -10.55M | -11.40M |
| EBIT | -19.13M | -14.34M | -6.60M | -11.47M | -13.49M |
| EBITDA | -17.63M | -12.98M | -5.39M | -11.14M | -13.30M |
| EPS Basic | -0.06 | 0.05 | 0.23 | -0.31 | -0.34 |
| Normalized Basic EPS | -0.26 | -0.22 | -0.14 | -0.23 | -0.26 |
| EPS Diluted | -0.06 | 0.05 | 0.23 | -0.32 | -0.35 |
| Normalized Diluted EPS | -0.26 | -0.22 | -0.14 | -0.23 | -0.26 |
| Average Basic Shares Outstanding | 188.06M | 184.67M | 180.47M | 174.90M | 170.75M |
| Average Diluted Shares Outstanding | 188.06M | 184.67M | 180.47M | 174.90M | 170.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 1,544.70% | 54.83% | 21.64% | -29.45% | -27.25% |